Medical device manufacturers making cosmetic / aesthetic products.
The TauTona Group lands FDA clearance for its TauTona tissue injector for fat grafting.
TauTona Group said the FDA has given 510(k) clearance for the company's tissue injector.
The device is the 2nd from Edison Park, Calif.-based TauTona. The single-use, hand-held injector is designed to simplify fat grafting through an even, controlled rate so the surgeon can focus on placement of the fat, according to a press release.
Syneron and Unilever subsidiaries have established a joint venture for home beauty devices, causing Syneron shares to jump by around 16%, this week.
Syneron Medical Ltd. (NSDQ:ELOS) stock surged by 16% for the week after its subsidiary, Syneron Beauty, said it will partner with Unilever Ventures's Iluminage Inc., on a joint venture, to be called Iluminage Beauty.
Solta Medical says it plans to lay of 40 workers, or 9% of its total workforce, and shutter a plant in Louisville, Colo.
Solta Medical (NSDQ:SLTM) yesterday detailed its new cost-cutting measures, saying it plans to lay off 40 workers, or roughly 9% of its total workforce "across all areas of the company."
Solta Medical shares are up after the medical device company swings to 3rd-quarter black ink and says it's considering 'strategic options,' including a possible sale, and inaugurates a plan to cut costs by lowering its head count.
Solta Medical (NSDQ:SLTM) shares gained today after the medical device company reported a swing to 3rd-quarter black ink and said it's considering a sale.
Company officials at Cynosure discuss the company's 3rd quarter earnings report. Cynosure reported losses of $1.3 million, or 6¢ per share, on sales of $60.7 million for the 3 months ended Sept. 30.
Shares of Cynosure fall after the medical aesthetics company puts red ink on the books for the 3rd quarter.
Cynosure (NSDQ:CYNO) shares are down 6% today after the medical aesthetics company reported a swing to 3rd-quarter red.
FDA regulators grant premarket approval to Allergan's Juvederm Voluma XC injectable gel for aesthetic volume restoration in the face.
Aesthetics company Allergan (NYSE:AGN) notched a U.S. market 1st with FDA approval for its Juvederm Voluma XC facial filler, the only filler indicated for age-related volume restoration in the cheeks.